BridgeBio Oncology Therapeutics, Inc.
BBOT
$9.71
$0.879.84%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.18% | -- | |||
| Total Receivables | 2,592.50% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 60.90% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 92.24% | -- | |||
| Total Current Assets | 0.72% | -- | |||
|
|
|||||
| Total Current Assets | 0.72% | -- | |||
| Net Property, Plant & Equipment | 2.68% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 6.00% | -- | |||
| Total Assets | 0.95% | -- | |||
|
|
|||||
| Total Accounts Payable | -39.86% | -- | |||
| Total Accrued Expenses | 51.80% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 5,233.33% | -- | |||
| Total Finance Division Other Current Liabilities | -92.36% | -- | |||
| Total Other Current Liabilities | -92.36% | -- | |||
| Total Current Liabilities | 13.28% | -- | |||
|
|
|||||
| Total Current Liabilities | 13.28% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -4.88% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 11.48% | -- | |||
|
|
|||||
| Common Stock & APIC | 1.97% | -- | |||
| Retained Earnings | -11.63% | -- | |||
| Treasury Stock & Other | -73.30% | -- | |||
| Total Common Equity | -13.85% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 8.06% | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 8.06% | -- | |||
|
|
|||||
| Total Common Equity | -13.85% | -- | |||
| Total Preferred Equity | 8.06% | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -1.34% | -- | |||
|
|
|||||